Study details
Enrolling now
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
The University of Texas Health Science Center, Houston
NCT IDNCT05989880ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 2.2 years
Ages
18+
Locations
1 site in TX
About this study
Researchers are testing whether SafeLM, a device that helps with intubation, can be used safely and effectively. The trial will also explore using SafeLM as a primary airway device without intubation assistance. It involves adults and aims to enroll 60 participants over approximately 805 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use SafeLM as a conduit for intubation using a bougie with video capability
- 2.Use SafeLM as a conduit for intubation using an endotracheal tube with video capability
- 3.Use SafeLM as a supraglottic airway device with video capability
- +1 more
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.